Business Description
NeuroOne Medical Technologies Corp
NAICS : 339113
SIC : 5047
7599 Anagram Dr., Eden Prairie, MN, USA, 55344
Description
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram(cEEG) and stereoelectrocencephalography(sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 49.31 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.27 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.35 | |||||
| 9-Day RSI | 75.15 | |||||
| 14-Day RSI | 74.8 | |||||
| 6-1 Month Momentum % | -67.74 | |||||
| 12-1 Month Momentum % | -78.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.6 | |||||
| Quick Ratio | 16.32 | |||||
| Cash Ratio | 15.89 | |||||
| Days Inventory | 222.03 | |||||
| Days Sales Outstanding | 86.08 | |||||
| Days Payable | 685.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -55.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -55.35 | |||||
| Operating Margin % | -7262.89 | |||||
| Net Margin % | -7207.55 | |||||
| ROE % | -103.54 | |||||
| ROA % | -94.03 | |||||
| ROIC % | -1474.84 | |||||
| ROC (Joel Greenblatt) % | -2461.34 | |||||
| ROCE % | -101.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 167.27 | |||||
| PB Ratio | 2.27 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| EV-to-EBIT | -1.5 | |||||
| EV-to-EBITDA | -1.51 | |||||
| EV-to-Revenue | 108.1 | |||||
| EV-to-Forward-Revenue | 5.54 | |||||
| EV-to-FCF | -1.66 | |||||
| Price-to-Net-Current-Asset-Value | 2.39 | |||||
| Price-to-Net-Cash | 2.49 | |||||
| Earnings Yield (Greenblatt) % | -66.67 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:NMTC
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.159 | ||
| EPS (TTM) ($) | -0.84 | ||
| Beta | 1.17 | ||
| Volatility % | 102.33 | ||
| 14-Day RSI | 74.8 | ||
| 14-Day ATR ($) | 0.172355 | ||
| 20-Day SMA ($) | 1.391005 | ||
| 12-1 Month Momentum % | -78.34 | ||
| 52-Week Range ($) | 0.5101 - 6.8 | ||
| Shares Outstanding (Mil) | 16.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeuroOne Medical Technologies Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||